Chemotherapy (journal)
Chemotherapy (journal)[edit]
Chemotherapy is a peer-reviewed medical journal that focuses on the field of chemotherapy, which is the treatment of disease by the use of chemical substances, especially the treatment of cancer by cytotoxic and other drugs. The journal publishes original research articles, reviews, and case reports related to the development and application of chemotherapeutic agents.
History[edit]
The journal was established in 1956 and has since been a prominent publication in the field of medical research related to chemotherapy. It is published by S. Karger AG, a Swiss academic publisher known for its contributions to the medical and scientific community.
Scope[edit]
The scope of the journal includes, but is not limited to, the following areas:
- Development of new chemotherapeutic agents
- Mechanisms of action of chemotherapeutic drugs
- Clinical trials and studies on chemotherapy
- Drug resistance in chemotherapy
- Pharmacokinetics and pharmacodynamics of chemotherapeutic agents
- Combination therapies involving chemotherapeutic drugs
Editorial Board[edit]
The journal is managed by an editorial board composed of experts in the field of chemotherapy and related disciplines. The board is responsible for the peer-review process and ensuring the quality and relevance of the published content.
Publication Frequency[edit]
Chemotherapy is published bimonthly, providing six issues per year. Each issue contains a variety of articles that contribute to the ongoing research and development in the field of chemotherapy.
Access and Availability[edit]
The journal is available both in print and online. Subscribers can access the journal through the publisher's website, and individual articles can be purchased or accessed through institutional subscriptions.
Related Journals[edit]
Chemotherapy is part of a broader collection of journals published by S. Karger AG, which includes other titles in the fields of oncology, pharmacology, and medical research.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
